Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

This study has been terminated.
(Recruitment was suspended prematurely for safety concerns and closed after IDMC review)
Sponsor:
Information provided by (Responsible Party):
European Organisation for Research and Treatment of Cancer - EORTC
ClinicalTrials.gov Identifier:
NCT00646659
First received: March 27, 2008
Last updated: January 7, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2011
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)